Company: XOMAP
Filing Date: 2025-10-03
Form Type: 424B5
Source: 0001193125-25-230393
Chunk: 50

Company: XOMA Royalty Corp
Filing Date: 2025-10-03
Form: 424B5
Chunk 50
---
 under the Securities Act.

The Agent is not required to sell any specific number or dollar amount of our Series B Depositary Shares but has agreed to use commercially reasonable
efforts, consistent with its normal trading and sales practices, as our sales agent and on the terms and subject to the conditions set forth in the Sales Agreement, to sell the Series B Depositary Shares offered on terms agreed upon by the Agent and
us. If we choose to offer our Series B Depositary Shares, we will instruct the Agent as to the number of shares to be sold by it as our sales agent, the minimum or average minimum price per share and the date or dates on which such shares are to be
sold. We may instruct the Agent not to sell our Series B Depositary Shares if the sales cannot be effected at or above a price designated by us. The Agent may decline to accept any such instructions that we may provide to it from time to time. We or
the Agent may suspend the offering of Series B Depositary Shares by the Agent upon notice to the other party.

If shares of our Series B Depositary Shares
are sold by the Agent, the Agent has agreed to confirm to us in writing the number of shares sold on the applicable trading day and the related gross sales price and net sales price of those shares on the immediately following trading day. We will
report at least quarterly the number of shares of our Series B Depositary Shares sold through the Agent, under the Sales Agreement, information concerning the net proceeds from those sales and the aggregate compensation paid to the Agent with
respect to such sales.

We will pay the Agent an aggregate commission of up to 3.0% of the gross sales price per share of Series B Depositary Shares sold
through the Agent, under the Sales Agreement. We have also agreed to reimburse the Agent for certain specified expenses, including the reasonable and documented
out-of-pocket fees and disbursements of its legal counsel in an aggregate amount not to exceed $75,000, in addition to certain ongoing disbursements of its legal
counsel. The remaining sales proceeds, after deducting any transaction fees, transfer taxes or similar taxes or fees imposed by any governmental, regulatory or self-regulatory organization in respect of the sale of the Series B Depositary Shares,
will be our net proceeds (before the expenses referred to in the next paragraph) from the sale of the Series B Depositary Shares in the offering.

We
estimate that the total expenses payable by us in connection with the establishment of the program to